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To assess changes in the retinal nerve fiber layer (RNFL) andmacula in subjects with car-
diovascular risk factors or subclinical ischemia.
Design
Prospective and observational study.
Methods
A total of 152 healthy men underwent cardiovascular examination, including quantification
of subclinical atheroma plaques by artery ultrasound scans, blood analysis, and a complete
ophthalmic evaluation, including spectral-domain optical coherence tomography. The vari-
ables registered in cardiovascular examination were quantification of classic major risk fac-
tors, subclinical atheroma plaques by artery ultrasound scans, and analytical records. The
ophthalmic evaluation registered RNFL andmacular thickness.
Results
Mean subject age was 51.27±3.71 years. The 40 subjects without classic cardiovascular
risk factors did not show differences in RNFL andmacular thicknesses compared with the
112 subjects with at least one risk factor (except in sector 9 that showed higher thicknesses
in subjects with1 risk factor). Comparison between the group of subjects with and without
atheroma plaques revealed no differences in RNFL andmacular thicknesses. The sub-anal-
ysis of subjects with subclinical atheroma plaques in the common carotid artery revealed a
significant reduction in central macular thickness in the left eye compared with the right eye
(p = 0.016), RNFL in the superior quadrant (p = 0.007), and the 11 o'clock sector (p =
0.020). Comparison between smokers and nonsmokers revealed that smokers had







Citation: Garcia-Martin E, Ruiz-de Gopegui E,
León-Latre M, Otin S, Altemir I, Polo V, et al.
(2017) Influence of cardiovascular condition on
retinal and retinal nerve fiber layer measurements.
PLoS ONE 12(12): e0189929. https://doi.org/
10.1371/journal.pone.0189929
Editor: Sanjoy Bhattacharya, Bascom Palmer Eye
Institute, UNITED STATES
Received: March 28, 2017
Accepted: December 5, 2017
Published: December 22, 2017
Copyright:© 2017 Garcia-Martin et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The AWHS is funded by the National
Center for Cardiovascular Research (Carlos III
Health Institute, Madrid) and the Aragon Institute
of Health Sciences. There are no other financial
disclosures.
Competing interests: The authors have declared
that no competing interests exist.
significant thinning of the central macular thickness (p = 0.034), the nasal RNFL quadrant
(p = 0.006), and the 3 and 5 o'clock sectors (p = 0.016 and 0.009).
Conclusions
Classic cardiovascular risk factors do not cause RNFL or macular thickness reduction, but
tobacco smoking habit reduces nasal RNFL thickness. Subclinical atherosclerosis in the
common carotid artery associates a reduction in central macular and nasal RNFL quadrant
thicknesses in the left eye compared with the right eye.
Introduction
Numerous studies have analyzed the ability of optical coherence tomography (OCT) to detect
retinal nerve fiber layer (RNFL) thickness abnormalities and changes in the macula of patients
with diverse neurodegenerative diseases, as a view of the "window to the brain" [1,2]. These
objective morphologic changes in the retinal and RNFL structures can be used for the diagno-
sis, prognosis, and follow-up of axonal neurodegeneration, and each neurodegenerative dis-
ease seems to show distinctive brain and RNFL atrophy patterns [3–5].
Chronic microvascular ischemic changes in the brain often lead to cognitive impairment
and other neurologic deficits. Signs of ischemia are detected on brains scans, most typically
magnetic resonance imaging. Imaging reveals small areas in the brain where blood vessels
have ruptured or clotted off, leading to extremely small areas of stroke and neurodegeneration.
Cognitive deficits and neurodegeneration may be associated with impaired synaptic transduc-
tion. A very high percentage of older adults may suffer from chronic microvascular changes,
and RNFL defects may be the earliest signs of neurodegeneration due to ischemic events, even
before the patient becomes symptomatic or brain damage can be detected by classic neuroim-
aging [1–3].
In the present study, we evaluated healthy subjects without a previous history of ocular or
cardiovascular disease selected from the “Aragon Workers´ Health Study (AWHS)”, a longitu-
dinal cohort study designed to identify risk factors for the development of preclinical and clini-
cal atherosclerosis [6]. We evaluated the cardiovascular risk factors of the sample, the
subclinical atheroma plaques by ultrasound scans, and specific analytical records to analyze
whether those subjects with a higher cardiovascular risk or subclinical atheroma plaques had a
significant reduction in macula and RNFL measurements determined by OCT.
Methods
A total of 152 healthy male subjects were recruited and evaluated for this cross-sectional study
from September 2013 to September 2015. Male staff from a manufacturing company (General
Motors, Zaragoza, Spain) was offered to voluntarily take part in the study. 184 subjects were
approached, 21 were not included due to not meeting the inclusion criteria.173 subjects were
included in the beginning of the study, but eight subjects had to be excluded after being diag-
nosed with several ophthalmological conditions (chronic open angle subclinical glaucoma was
detected in 5 subjects, cataract in 2 patients and a macular hole in one patient). Another three
subjects dropped-out from the study. All procedures adhered to the tenets of the Declaration
of Helsinki, and The Aragon regional government’s Ethics Committee for Clinical Research
(CEICA) reviewed and approved this study. The informed written consent was signed by all
participants before the inclusion in the study.
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Cardiovascular examination for all the subjects enrolled in the study included quantifica-
tion of the classic major risk factors, determination of the presence of subclinical atherosclero-
sis, and analytical records. The classic major and independent risk factors for cardiovascular
disease are: cigarette smoking, diabetes mellitus, elevated blood pressure, and dyslipidemia.
For this study, we considered elevated blood pressure as systolic blood pressure140 mmHg
and diastolic blood pressure90 mmHg, or self-reported use of antihypertensive medication.
Dyslipidemia was defined as total cholesterol240 mg, low-density lipoprotein (LDL)160,
high-density lipoprotein (HDL) <40 mg/dl, or lipid-lowering medication. Diabetes was con-
sidered in patients with fasting plasma glucose126 or taking hypoglycemic medication.
Cardiovascular risk was estimated following the guidelines of the Pooled Cohort Risk
Assessment Equations, developed by the Risk Assessment Work Group, an arm of the Ameri-
can College of Cardiology/American Heart Association Cardiovascular Risk Guidelines. The
Pooled Cohort Equations estimate the 10-year primary risk of ASCVD [atherosclerotic cardio-
vascular disease: nonfatal myocardial infarction (heart attack), coronary heart disease death, or
stroke] among people without pre-existing cardiovascular disease between 40 and 79 years of
age. People are considered to be at "elevated" risk if the Pooled Cohort Equations predicted
risk is 7.5%, low risk <5%, and moderate risk 5–7.5% [7].
Subclinical atherosclerosis was defined by the presence of plaques in both carotid and both
femoral arteries determined using the Philips IU22 ultrasound system (Philips Healthcare,
Bothell, WA). Plaque was defined as a focal structure protruding0.5 mm into the lumen or
reaching a thickness50% of the surrounding intima. Examination of the carotid territory
included the terminal portion (10 mm) of the common carotid, the bulb, and the initial por-
tion (10 mm) of the internal and external carotid arteries. This method was previously pub-
lished [8].
The presence of coronary calcium was evaluated following the Agatston method, and was
considered as positive for any calcium score1 coronary artery calcification score (CACS)
[9]. The Agatston method was first described in 1990 as a novel way to measure coronary
artery calcium [10]. Agatston et al. used ultra-fast computed tomography to measure total cal-
cium scores based on the number, areas, and peak Hounsfield computed tomographic num-
bers of the calcified lesions detected [10].
A comprehensive ophthalmic evaluation was performed in all subjects, including best-cor-
rected visual acuity and fundus examination under pupil dilation, to rule out the presence of
any concomitant ocular pathology. Spectral domain optical coherence tomography (SD-OCT)
is a noninvasive, noncontact, and highly sensitive ophthalmic diagnostic imaging technology
that provides objective and precise in vivo measurements of macular and retinal nerve fiber
layer (RNFL) thicknesses. Structural analysis of the retina was performed using SD-OCT with
the Cirrus Photo OCT (Carl Zeiss Meditec Inc, Dublin, CA). OCT examination for this study
included the macular (for macular thickness analysis) and RNFL protocols. The same experi-
enced operator performed all scans and did not apply manual correction to the OCT output.
We used an internal fixation target because it provides the highest reproducibility and rejected
poor-quality scans prior to data analysis [11]. We assessed the image quality based on the sig-
nal strength measurement that combines the signal-to-noise ratio with the uniformity of the
signal within a scan (scale 1–10, where 1 is categorized as poor image quality and 10 as excel-
lent). We included images with a score higher than 7 for evaluation. The Cirrus OCT macular
cube 512 x 128 protocol provides a macular volume measure and retinal thickness values for
nine areas that correspond to the Early Treatment Diabetic Retinopathy Study chart. These
areas include a central 1-mm circle representing the fovea, and inner and outer rings measur-
ing 3 mm and 6 mm in diameter, respectively. The inner and outer rings are divided into four
quadrants each: superior, nasal, inferior, and temporal. The Cirrus OCT optic disc protocol
OCT and cardiovascular conditions
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generates 200 x 200 cube images with 200 linear scans enabling analysis of the RNFL of a
6-mm3 volume around the optic nerve. The thickness of the retinal nerve fiber layer is mea-
sured 3.4 mm from the centre of the optic disc. This distance was chosen by Zeiss because it
offers the best compromise between the thickness of the RNFL and interindividual variability.
For each scan series of RNFL measurements, we assessed the average thickness of each
quadrant (superior, nasal, inferior, and temporal).
All data analyses were performed using SPSS software version 20.0 (SPSS Inc., Chicago, IL).
The Kolmogorov-Smirnov test was used to assess sample distribution. For quantitative data
following a parametric distribution, differences between evaluation groups were compared
using Student´s t-test. For qualitative data, a chi square test was used for comparison. Correla-
tions between groups of study were determined using Pearson’s correlation coefficient. Finally,
a multivariate regression analysis was performed to identify basal RNFL or macular parame-
ters that were predictors of presence of classic cardiovascular risk factors or subclinical athero-
sclerosis. A p value of less than 0.05 was considered to be statistically significant.
Results
We enrolled 303 eyes from 152 healthy men in the study with a mean age of 51.27±3.71 years
(range: 42–58 years).
In the first analysis, we divided the sample into two groups to evaluate the presence of any
of the classic major cardiovascular risk factors (i.e., cigarette smoking, elevated blood pressure,
diabetes mellitus, and elevated serum cholesterol level): 40 subjects (26.3%) had no classic
major cardiovascular risk factors and 112 subjects (72.7%) had at least one risk factor. Mean
age of the group without risk factors was 50.78±3.47 years and that of the group with risk fac-
tors was 51.47±3.78 years. Mean intraocular pressure (IOP) was 14.21±2.43 mmHg for the
group without risk factors and 14.12±2.54 mmHg for the group with risk factors. The two
groups did not differ significantly with regard to age (p = 0.154), or IOP values (p = 0.691).
Mean values and comparison of the cardiovascular risk description (i.e., weight, height, body
mass index, systolic blood pressure, diastolic blood pressure, frequency, serum glucose levels,
total cholesterol levels, HDL cholesterol, LDL cholesterol, triglycerides, hematocrit, hemoglo-
bin, leucocytes, and platelets) and OCT measurements for the groups with and without classic
risk factors are shown in Table 1. OCT revealed no significant differences between the two
groups with regard to the RNFL measurements or the macular structure analysis.
In the second analysis, we divided the full population into two groups to evaluate the pres-
ence of atheroma plaques in carotid artery ultrasound scans. Group 1 comprised subjects with
no evidence of atheroma on the ultrasound scan (97 subjects, 63.8% of the total subjects in the
sample), and Group 2 comprised subjects with at least one plaque (55 subjects, 36.2% of the
sample), regardless of the thickness and number of plaques found. Mean age and IOP for
Group 1 were 50.40±3.54 years and 14.21±2.43 mmHg, respectively, and for Group 2, 51.28
±3.72 years and 14.23±2.39 mmHg, respectively. The two groups were not significantly differ-
ent with regard to age (p = 0.092) or IOP (p = 0.542). Mean OCT values for these two groups
and significance level based on comparison with Student’s t test are shown in Table 2. The two
groups did not differ significantly with regard to the RNFL measurements or macular structure
analysis.
The third analysis evaluated the homolateral effects on the eye depending on the laterality
of the atheroma plaques. We compared retinal and RNFL structures in the right eyes of the
subjects with and without signs of atheroma plaques in the right carotid. The same analysis
was performed for the left carotid territory and left eye. In subjects with signs of atheroma pla-
ques in the right carotid, we found a significant reduction in the RNFL superior quadrant
OCT and cardiovascular conditions
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Table 1. Mean, standard deviation (SD), and comparison of cardiovascular parameters and of retinal nerve fiber layer (RNFL) andmacular thick-
ness values obtained with the Cirrus High Definition optical coherence tomography (OCT) devicemeasured in subjects without classicmajor car-
diovascular risk factors and subjects with at least one classicmajor cardiovascular risk factor. Significant differences are marked in bold.
Abbreviations: LDL (low-density lipoprotein), HDL (high-density lipoprotein).
SUBJECTSWITHOUT
CARDIOVASCULAR RISK
FACTORS (n = 40)
SUBJECTSWITH
CARDIOVASCULARRISK
FACTORS (n = 112)
SIGNIFICANCE
(P)
Mean SD Mean SD
Cardiovascular parameters Weight 80.40 10.09 84.14 11.10 0.008
Height 171.53 6.78 171.79 6.49 0.759
Body Mass Index 27.27 2.57 28.51 3.34 0.003
Systolic Blood Pressure 121.53 11.41 125.65 13.96 0.018
Diastolic Blood Pressure 81.40 7.36 83.57 9.08 0.054
Frequency 67.27 11.09 69.99 12.25 0.81
Glucose level 95.31 8.64 100.79 19.46 0.015
Cholesterol total 209.52 21.87 225.72 38.40 <0.001
Cholesterol HDL 55.72 14.33 51.22 10.47 0.003
Cholesterol LDL 131.48 20.23 140.59 34.74 0.027
Triglycerides 111.46 48.80 169.72 106.66 <0.001
Hematocrit (%) 44.62 2.90 46.10 2.92 <0.001
Hemoglobin 15.23 1.03 15.54 0.93 0.015
Leucocytes 6.34 1.43 7.38 1.88 <0.001
Platelets 243.52 38.30 242.09 61.27 0.845
RNFL thickness Average 93.23 9.65 94.62 10.31 0.293
Superior 114.53 15.43 118.78 19.32 0.076
Nasal 74.75 11.49 72.23 14.09 0.140
Inferior 121.89 17.91 123.19 14.39 0.518
Temporal 62.19 9.53 64.45 10.68 0.094
Sector 1 118.73 23.06 123.12 29.29 0.225
Sector 2 104.10 17.92 109.10 27.39 0.128
Sector 3 91.26 16.90 88.43 22.14 0.297
Sector 4 60.64 11.13 59.31 11.76 0.377
Sector 5 72.32 14.39 68.87 15.28 0.079
Sector 6 103.62 23.44 103.63 22.73 0.996
Sector 7 138.57 25.22 139.31 24.38 0.816
Sector 8 123.40 22.11 127.00 20.26 0.183
Sector 9 60.06 10.51 65.06 14.58 0.005
Sector 10 51.77 10.30 52.82 11.25 0.462
Sector 11 74.57 12.85 75.50 12.40 0.569
Sector 12 116.59 22.98 119.38 24.38 0.372
Macular thickness Fovea 270.99 23.98 266.57 22.13 0.135
Inner superior 334.19 23.19 331.18 16.30 0.211
Inner nasal 337.48 24.36 334.21 17.84 0.207
Inner inferior 332.62 17.25 329.71 16.33 0.180
Inner temporal 321.31 16.90 318.27 15.61 0.145
Outer superior 287.84 15.91 284.96 13.85 0.127
Outer nasal 306.75 18.44 304.61 17.16 0.348
Outer inferior 277.40 16.15 276.19 13.43 0.518
Outer temporal 272.09 14.86 270.37 12.12 0.312
https://doi.org/10.1371/journal.pone.0189929.t001
OCT and cardiovascular conditions
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(115.17±15.20 μm) compared with subjects without atheroma plaques in the right carotid
(123.41±33.10 μm; p = 0.044), and also in the RNFL 2 o’clock sector (101.11±20.35 μm vs
114.56±43.81 μm; p = 0.014) (Table 3). In the left eye examination, a significant reduction was
found in subjects with atheroma plaques in the left carotid compared with subjects without
plaques in the central macular thickness (266.49±19.18 vs 276.89±23.66 μm; p = 0.016), in the
RNFL superior quadrant (116.21±15.23 vs 124.89±15.23 μm; p = 0.006), and in RNFL 11
o’clock sector (73.18±12.13 vs 79.07± 10.72 μm; p = 0.018). The RNFL 11 o’clock sector is
located in the superior pole of the optic disc (Table 4). We repeated the analysis using any ath-
eroma plaques in any left-sided location (carotid and femoral arteries) for the left eye, and sim-
ilarly for right-sided territories and the right eye. The results were similar to those found with
respect to the carotid arteries. Lastly, the sub-analysis of subjects with atheroma plaques in the
common carotid artery revealed similar results to those found in subjects with atheroma pla-
ques in the left carotid. These group of individuals showed reduced measurements in the left
eye compared to the right eye in the central macular thickness (p = 0.016), the superior RNFL
quadrant (p = 0.007), and the 11 o’clock RNFL sector (p = 0.020).
Table 2. Mean, standard deviation (SD), and comparison of retinal nerve fiber layer (RNFL) andmacular thickness values obtained with the Cirrus
High Definition optical coherence tomography (OCT) device between the group without atheroma plaques and the group with at least one ather-
oma plaque.
OCTmeasurements NO ATHEROME PLAQUES IN
ULTRASOUND (n = 97)





Mean SD Mean SD
RNFL thickness Average 94.23 9.60 94.27 10.51 0.973
Superior 116.78 14.86 118.20 20.47 0.513
Nasal 72.81 12.21 72.97 14.27 0.918
Inferior 123.48 16.15 122.41 14.91 0.559
Temporal 64.04 10.93 63.70 10.06 0.782
Sector 1 120.48 22.59 122.91 30.77 0.458
Sector 2 105.68 18.39 109.13 28.91 0.247
Sector 3 89.62 17.15 88.91 23.05 0.773
Sector 4 59.28 11.42 59.93 11.72 0.633
Sector 5 69.60 14.39 69.93 15.59 0.854
Sector 6 104.21 21.79 103.24 23.63 0.721
Sector 7 140.16 26.56 138.42 23.20 0.549
Sector 8 126.83 22.84 125.49 19.37 0.584
Sector 9 64.00 13.54 63.52 13.95 0.770
Sector 10 52.28 10.70 52.71 11.21 0.739
Sector 11 75.75 13.97 74.91 11.46 0.570
Sector 12 121.23 25.45 116.91 22.91 0.126
Macular thickness Fovea 268.46 21.80 267.31 23.33 0.670
Inner superior 332.75 20.30 331.49 17.11 0.563
Inner nasal 334.97 21.01 335.20 19.07 0.922
Inner inferior 331.71 16.02 329.69 16.99 0.305
Inner temporal 320.12 15.26 318.41 16.45 0.367
Outer superior 287.05 14.18 284.86 14.64 0.201
Outer nasal 306.11 17.36 304.57 17.63 0.459
Outer inferior 277.48 14.13 275.88 14.27 0.342
Outer temporal 272.18 13.14 269.91 12.72 0.139
https://doi.org/10.1371/journal.pone.0189929.t002
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In the fourth analysis, we divided the sample according to the cardiovascular risk calculated
according to the Framingham criteria, creating Group 1 (comprising 114 subjects with no car-
diovascular risk, 75% of the sample) and Group 2 (comprising 38 subjects with some degree of
cardiovascular risk, 25% of the sample). Mean age and IOP were 52.61±3.80 years and 14.32
±2.54 mmHg, respectively, for subjects that did not meet the Framingham criteria and 53.22
±3.58 years and 14.12±2.38 mmHg, respectively, for subjects that did meet the Framingham
cardiovascular criteria. Age and IOP were not significantly different between groups
(p = 0.109 and 0.222, respectively). Mean OCT values for these two groups and the differences
between groups based on Student’s t test are shown in Table 5. The two groups did not differ
significantly with regard to the RNFL measurements or the macular structure analysis.
In the fifth analysis, we divided the sample into 92 nonsmokers and 47 smokers. We
excluded 13 subjects whose smoking habit was unknown. Mean age of the nonsmokers was
51.35±3.81 years and that of the smokers was 51.11±3.48 (p = 0.596). Mean IOP values of the
nonsmokers was 14.13±2.45 and for the smokers, 14.16±2.55 (p = 0.709). Figs 1 and 2 show
Table 3. Mean, standard deviation (SD), and comparison of retinal nerve fiber layer (RNFL) andmacular thickness values obtained with the Cirrus
High Definition optical coherence tomography (OCT) device in the right eye, between the group with and without atheroma plaques in the right
carotid.
OCT measurements Subjects without atheroma
plaques in the right carotid
Subjects with atheroma plaques
in the right carotid
Significance
(P)
Mean SD Mean SD
RNFL thickness Average 94.23 9.38 96.59 13.59 0.254
Superior 115.17 15.19 123.41 33.09 0.044
Nasal 73.83 12.67 74.74 19.311 0.750
Inferior 122.67 15.15 125.26 15.21 0.384
Temporal 65.59 12.20 63.44 8.04 0.337
Sector 1 120.15 23.44 130.85 45.88 0.072
Sector 2 101.11 20.35 114.56 43.81 0.014
Sector 3 90.53 18.18 93.85 37.87 0.483
Sector 4 60.22 11.70 61.50 14.55 0.600
Sector 5 70.66 14.65 68.68 13.96 0.486
Sector 6 102.19 21.13 105.82 23.26 0.392
Sector 7 136.94 23.45 142.41 24.30 0.239
Sector 8 128.74 22.79 127.65 17.93 0.798
Sector 9 66.46 15.73 64.97 10.93 0.606
Sector 10 53.32 13.23 52.82 10.35 0.841
Sector 11 76.93 12.81 72.24 11.16 0.056
Sector 12 119.34 23.91 119.71 25.32 0.939
Macular thickness Fovea 268.52 24.32 263.94 25.39 0.348
Inner superior 333.07 15.12 328.61 23.40 0.195
Inner nasal 335.76 17.21 332.73 24.44 0.424
Inner inferior 331.09 15.82 328.73 22.05 0.495
Inner temporal 319.47 14.45 317.82 22.11 0.613
Outer superior 285.66 14.28 283.70 15.70 0.499
Outer nasal 305.55 15.96 304.12 20.77 0.674
Outer inferior 276.34 14.56 277.70 15.03 0.641
Outer temporal 271.20 12.13 270.88 14.82 0.900
https://doi.org/10.1371/journal.pone.0189929.t003
OCT and cardiovascular conditions
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the OCT measurement values for the smokers and nonsmokers groups. The central macular
thickness was significantly thinner in the smokers (263.82±21.09 μm vs 269.78±23.16 μm;
p = 0.034). A significant reduction was also detected in smokers in the RNFL nasal quadrant
(69.77±12.16 vs 74.31±13.79 μm; p = 0.006), RNFL 3 o’clock sector (84.98±17.77 vs 91.17
±21.88 μm; p = 0.016), and RNFL 5 o’clock sector (66.38±13.62 vs 71.28±15.48 μm; p = 0.009).
Finally, the multivariate regression analysis demonstrated that RNFL or macular parame-
ters are not predictors of presence of classic cardiovascular risk factors or subclinical athero-
sclerosis in our population.
Discussion
Because the RNFL comprises the first axons of the visual pathway and is unmyelinated, it can
be considered a unique anatomic model that may provide insight into the pathophysiologic
processes of neurodegenerative diseases. In fact, previous OCT studies have emphasized the
role of the visual pathway as an ideal structure for exploring neurodegeneration and have dem-
onstrated the potential of the method to longitudinally monitor structural changes in
Table 4. Mean, standard deviation (SD), and comparison of retinal nerve fiber layer (RNFL) andmacular thickness values obtained with the Cirrus
High Definition optical coherence tomography (OCT) device in the left eye, between the group with and without atheroma plaques in the left
carotid.
OCT measurements Subjects without atheroma
plaques in the left carotid
Subjects with atheroma plaques
in the left carotid
Significance
(P)
Mean SD Mean SD
RNFL thickness Average 92.91 9.66 96.07 9.56 0.120
Superior 116.21 15.23 124.89 15.29 0.007
Nasal 71.73 12.18 71.46 13.14 0.920
Inferior 121.66 15.66 124.46 16.21 0.398
Temporal 62.05 9.17 63.82 8.75 0.355
Sector 1 119.18 23.31 128.39 29.70 0.077
Sector 2 110.42 21.40 116.11 21.99 0.210
Sector 3 87.56 16.16 85.46 20.29 0.558
Sector 4 58.43 10.75 58.89 10.58 0.838
Sector 5 69.14 15.81 70.14 15.31 0.762
Sector 6 103.43 22.71 106.93 28.41 0.487
Sector 7 138.91 26.13 142.36 23.46 0.523
Sector 8 123.44 19.47 123.96 20.86 0.900
Sector 9 61.50 12.03 60.61 14.15 0.733
Sector 10 51.52 9.75 52.07 6.99 0.777
Sector 11 73.18 12.13 79.07 10.72 0.020
Sector 12 115.58 23.34 121.36 22.24 0.236
Macular thickness Fovea 266.49 19.18 276.89 23.65 0.016
Inner superior 331.68 19.55 334.11 16.64 0.550
Inner nasal 335.19 21.00 336.70 17.57 0.728
Inner inferior 330.99 15.05 329.96 16.36 0.753
Inner temporal 318.89 14.62 321.52 16.20 0.410
Outer superior 285.33 13.48 288.78 17.51 0.261
Outer nasal 304.92 16.96 305.11 20.77 0.959
Outer inferior 276.66 13.41 275.30 15.64 0.645
Outer temporal 270.26 12.31 271.70 16.35 0.607
https://doi.org/10.1371/journal.pone.0189929.t004
OCT and cardiovascular conditions
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neurologic disorders such as multiple sclerosis, Alzheimer disease, Parkinson’s disease, and
also some psychiatric diseases such as schizophrenia [12]. The spatial resolution of OCT scans
is comparable to that of histologic slices [13].
Decreased RNFL thickness may reflect retinal neuronal-ganglion cell death. In the sectorial
analysis of the RNFL, a deeper reduction in the temporal quadrant thickness compared to the
other three quadrants is observed in neurodegenerative diseases [14–16]. Also, temporal
RNFL thickness is reduced in patients with some mitochondrial disorders, including Leber’s
hereditary optic neuropathy and other neurologic conditions. This predominantly temporal
reduction of the RNFL thickness seems to be consistent in the neuro-ophthalmologic litera-
ture, highlighting its usefulness as a biomarker of neurodegeneration. On the other hand, glau-
coma leads to a greater decrease in the inferior RNFL quadrant thickness [17], and patients
with obstructive sleep apnea syndrome present with RNFL thinning in the nasal quadrant and
choroidal thickening (this change may be caused by the pathophysiology of the neurodegen-
eration process in obstructive sleep apnea syndrome) [18]. Therefore, each pathology may lead
to a different fingerprint of damage in the optic nerve [19].
Table 5. Mean, standard deviation (SD), and comparison of retinal nerve fiber layer (RNFL) andmacular thickness values obtained with the Cirrus
High Definition optical coherence tomography (OCT) device in the group with and without cardiovascular risk according to the Framingham
criteria.








Mean SD Mean SD
RNFL thickness Average 93.92 10.01 94.31 10.23 0.776
Superior 117.00 15.20 117.79 19.43 0.749
Nasal 71.35 12.24 73.38 13.81 0.257
Inferior 124.17 15.40 122.33 15.41 0.370
Temporal 63.21 11.46 64.00 10.06 0.572
Sector 1 121.47 22.72 122.06 29.29 0.873
Sector 2 105.59 22.16 108.52 26.21 0.385
Sector 3 87.31 17.70 89.85 21.79 0.361
Sector 4 59.08 10.89 59.80 11.78 0.642
Sector 5 67.52 13.88 70.47 15.41 0.142
Sector 6 105.19 22.67 102.97 22.81 0.465
Sector 7 139.60 23.44 138.92 25.06 0.835
Sector 8 127.59 21.73 125.51 20.50 0.454
Sector 9 63.49 14.59 63.75 13.50 0.888
Sector 10 51.83 11.94 52.73 10.71 0.539
Sector 11 74.47 12.68 75.46 12.50 0.553
Sector 12 118.15 25.73 118.59 23.55 0.890
Macular thickness Fovea 267.84 18.55 267.89 23.92 0.988
Inner superior 332.25 14.71 331.86 19.56 0.872
Inner nasal 335.60 16.54 334.95 20.87 0.807
Inner inferior 331.08 15.29 330.31 17.06 0.729
Inner temporal 320.52 14.38 318.53 16.52 0.352
Outer superior 285.08 14.12 285.91 14.63 0.667
Outer nasal 304.08 16.85 305.55 17.77 0.530
Outer inferior 277.25 14.32 276.24 14.21 0.596
Outer temporal 271.13 13.19 270.72 12.85 0.810
https://doi.org/10.1371/journal.pone.0189929.t005
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Cognitive impairment and neurologic degeneration are directly linked to chronic micro-
vascular ischemic changes in the brain, which are often related to cardiovascular risk factors,
such as cholesterol serum levels [20–22]. Many diseases are characterized by impaired choles-
terol turnover in the brain. Cholesterol is important for synaptic transmission, and there is a
link between cholesterol metabolism defects and neurodegenerative disorders [23,24].
Fig 1. Bar graphs of optical coherence tomographymeasurements in microns.Representation in bar
graphs of retinal nerve fiber layer (RNFL).
https://doi.org/10.1371/journal.pone.0189929.g001
Fig 2. Bar graphs of optical coherence tomographymeasurements in microns.Representation in bar
graphs of macular thickness values obtainedwith the Cirrus High Definition optical coherence tomography
device in smokers and nonsmokers.
https://doi.org/10.1371/journal.pone.0189929.g002
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In our study, we evaluated the implications and possible contributions of classic cardiovas-
cular risk factors to subclinical alterations of the RNFL. The quantitative relationship between
cardiovascular factors and risk of cardiovascular events was elucidated by the Framingham
Heart Study and other studies [25]. These studies demonstrated that the major risk factors are
additive in predictive power. Accordingly, a person’s total risk can be estimated by summing
the risk afforded by each of the major risk factors. The American Heart Association and the
American College of Cardiology published joint recommendations for medical interventions
in patients with cardiovascular risk and other forms of atherosclerotic disease [26]. A similar
potential exists for risk reduction in patients without an established cardiovascular risk (pri-
mary prevention). The risk status of persons without cardiovascular risk varies greatly.
The effects of cigarette smoking on RNFL measurements were analyzed, and a significant
tendency toward nasal quadrant thinning of the RNFL was observed in smokers compared to
nonsmokers. Thus, we postulate that tobacco affects the blood vessels in the deep retinal struc-
tures and that early thinning in the nasal area of the optic head nerve in the OCT scans might
suggest other than neurodegenerative damage.
Our results revealed a significant reduction in the superior quadrant of the RNFL in the
right eye of subjects with atheroma plaques in the right carotid artery territory. The same thin-
ning was observed in the superior pole of the left optic disc in subjects with some degree of left
carotid artery stenosis. Subjects with common carotid artery atheroma plaques presented a
thinner superior area of the RNFL in the left eye. A potential explication of this finding may be
that superior areas of the RNFL are more sensitive to be damaged by minimum blood flow
defects, especially in the left eye. Ocular blood hypoperfusion is associated with many ophthal-
mic disorders, such as neovascular glaucoma, ocular ischemic syndrome, and vascular occlu-
sions; and these disorders usually cause early defects in the superior area of the RNFL [27].
Defects in retinal ganglion cells are reported in patients with ictus and brain hypoxia, although
optic atrophy and retinal nerve fiber layer defects may not be detected on fundoscopy, and
these defects are more clearly detected by OCT than circumpapillary retinal nerve fiber layer
defects. Transneuronal retrograde degeneration has been demonstrated [28,29]. As the oph-
thalmic artery is a branch of the internal carotid, and thus responsible for vascularization of
the main structures in the eye, microvascular ischemia and carotid stenosis may lead to choroi-
dal hypoperfusion, attenuation of the choroidal vessels, and alterations in the integrity of the
RNFL, as measured by OCT [30].
To our knowledge, this is the first study to demonstrate a direct relation between subclinical
stenosis of the carotid arteries and its branches measured by supra-aortic ultrasound scans,
and the retinal structure analysis measured by OCT. These findings suggest that general
screening with OCT in cases of suspected stenosis could be valuable to support the diagnosis
or early detection of subclinical atrophy in the RNFL. This reduction in the RNFL seems to be
selective for the superior quadrant–a remarkable fact given the RNFL alterations described in
other neurologic conditions seems to be found preferentially in the temporal quadrant. Never-
theless, when OCT detects subclinical thinning in other areas of the retinal structure (outside
the superior quadrant), this thinning should not be exclusively attributed to chronic ischemia
and we should search for any neurodegenerative diseases or glaucoma, entities for which reti-
nal abnormalities measured by OCT have been widely described.
We evaluated atheromatous plaques in the carotid, or intimal thickening, but no significant
stenosis was detected in any subject. A possible explanation is that incipient and subclinical
atherosclerosis in the carotid may extend distally to the arterioles and capillaries, including the
eye area. Another possible explanation is that structural changes of atherosclerosis in this very
early stage also affect other metabolic or molecular structures, such as neuroretinal areas.
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A limitation of this study is that only men were included. Women were excluded from
recruitment in an attempt to avoid selection bias because men are more frequently affected by
cardiovascular conditions. Another possible limitation is the sample size because a larger sam-
ple would allow for different subgroups to be established for independent evaluation of each
risk factor (e.g., smoke habit only, without diabetes, dyslipidemia, etc.). Further investigation
is required to clarify the effect of sex and to evaluate a larger sample.
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